Picture of Cyxone AB logo

CYXO — Cyxone AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cyxone Announces Positive Results From Regulatory Toxicology Studies Of Rabeximod

Oct 30 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE ANNOUNCES POSITIVE RESULTS FROM REGULATORY
TOXICOLOGY
STUDIES OF RABEXIMOD
    * POSITIVE STUDY READ-OUT SHOWS A FAVORABLE SAFETY PROFILE
OF
CANDIDATE DRUG, THUS ENFORCING SIMILAR OUTCOMES FOUND IN A
PREVIOUSLY CONDUCTED TWELVE-WEEK TOXICOLOGY STUDY

Source text for Eikon:  ID:nWkr1YWBYT 
Further company coverage:  CYXO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))

Recent news on Cyxone AB

See all news